Syringomyelia
14
3
4
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (14)
Abnormality of the Central Canal of the Spinal Cord in Syringomyelia in a Patient With a Basal Skull Malformation
Genetic Analysis of the Chiari I Malformation
Extracellular Vesicles for the Treatment of Syringomyelia
A Prospective Natural History Study of Patients With Syringomyelia
Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia
Subarachnoid-Subarachnoid (S-S) Bypass Versus Adhesion Lysis in Spinal Arachnoiditis and Syringomyelia
The Therapeutic Effect of Betaine in Syringomyelia
The Therapeutic Effect of Thalidomide in Syringomyelia
Development of a Patient-reported Outcome Measure for Chiari Malformation and Syringomyelia
Impact of Peripheral Afferent Input on Central Neuropathic Pain
Investigation of the Effects of Exercise on Patients With Chiari Malformation
Clinical Trial of a Serious Game for Individuals With SCI/D
Study and Surgical Treatment of Syringomyelia
Establishing the Physiology of Syringomyelia